The new service rolling out in Houston is part Uber for kids, part carpool. Photo courtesy of HopSkipDrive

Living in Houston is great, but it does present some challenges — especially for busy families. Imagine this scenario: it's Tuesday morning, Mom has an early office meeting, Dad has to fly out of IAH on business, and three kids have to be transported to two different schools ... and it all has to happen before 8 am.

That scene probably plays closer to reality for many Bayou City parents. Add into it the regular crush of our city's congestion and it's enough for anyone to lose their mind.

Enter HopSkipDrive. Part Uber, part carpool the service just launched in Houston, billing itself as a safe an innovative transportation solution for both families and schools. It's already working with more than 170 schools and districts nationwide in cities in Arizona, California, Colorado, and Virginia, as well as Washington, D.C.

The company provides transit solutions for students of all levels and abilities who may have different schedules from day-to-day, as well as youth in foster care and families whose school choice placements don't fit neatly into a bus routing plan.

The system works similarly to other ride shares. Parents download the HopSkipDrive app or use the company's website to request rides for children who are at least six years old. Parents can customize ride instructions with notes about carpool line, pickup and drop-off procedures, and other details. Before the ride, parents receive a photo profile of their CareDriver, which they can share with their child and their school. During the ride, parents receive progress alerts at each step.

If all that has alarm bells going off in parents' and educators' heads, HopSkipDrive understands, and the company assures them it has a rigorous screening procedure for its drivers. Every CareDriver has at least five years of care-giving experience and has passed a 15-point certification process.

This certification is a stringent vetting process, including fingerprinting, background checks using FBI and Department of Justice database searches, driving record checks, and in-person meetings. Drivers must own or lease a four-door vehicle that is not more than 10 years old that can seat between four and seven passengers, and must pass a yearly 19-point inspection.

In addition, parents can get live text notifications during their child's ride, HopSkipDrive's Safe Ride Support (SRS) is the only U.S.-based team in the industry that monitors every ride in real time. Staffed with former 911 operators, EMTs, childcare specialists, and parents, SRS ensures every rider is delivered safely to their destination.

"As a working mother of two, I understand how challenging it is to balance your children's ever-changing daily schedules with workplace demands," says Joanna McFarland, the company's founder and CEO in a press release that announced the company's Houston launch. "Parents shouldn't have to choose between their careers and their children's education and activities, but that tough choice is very real for countless families. HopSkipDrive wants parents to take comfort in knowing they have a caregiver to rely on to get their kids where they need to go, safely and without worry. We're thrilled to arrive in the Greater Houston Area to answer the transportation needs of many students, families and schools."

And individual schools or school districts can also partner with the ride share service for their student transportation needs.

"HopSkipDrive is not only 60 percent less expensive than our previous car service solution, but far more reliable," says Mike Hush, director of transportation with Littleton Public Schools in Colorado. "We had worked with HopSkipDrive for only a few weeks before we quadrupled the number of students riding with CareDrivers."

The company touts itself as both an asset and a success in cities around the country. With its working-mom founding team, heightened approach to safety, and real-time technology approach, HopSkipDrive could provide a valuable service for Houston's busy working families.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

3 Houston innovators to know this week

who's who

Editor's note: Welcome to another Monday edition of Innovators to Know. Today I'm introducing you to three Houstonians to read up about — three individuals behind recent innovation and startup news stories in Houston as reported by InnovationMap. Learn more about them and their recent news below by clicking on each article.

Sean Kelly, CEO and co-founder of Amperon

Amperon CEO Sean Kelly joins the Houston Innovators Podcast to share his company's growth and expansion plans. Photo via LinkedIn

The technology that Amperon provides its customers — a comprehensive, AI-backed data analytics platform — is majorly key to the energy industry and the transition of the sector. But CEO Sean Kelly says he doesn't run his business like an energy company.

Kelly explains on the Houston Innovators Podcast that he chooses to run Amperon as a tech company when it comes to hiring and scaling.

"There are a lot of energy companies that do tech — they'll hire a large IT department, they'll outsource a bunch of things, and they'll try to undergo a product themselves because they think it should be IP," he says on the show. "A tech company means that at your core, you're trying to build the best and brightest technology." Continue reading.

Amanda Burkhardt, CEO of Phiogen

Spun out of Baylor College of Medicine, Phiogen was selected out of 670 companies to pitch at SXSW earlier this month. Photo via LinkedIn

A new Houston biotech company won a special award at the 16th Annual SXSW Pitch Award Ceremony earlier this month.

Phiogen, one of 45 companies that competed in nine categories, was the winner for best inclusivity, much to the surprise of the company’s CEO, Amanda Burkhardt.

Burkhardt tells InnovationMap that while she wanted to represent the heavily female patient population that Phiogen seeks to treat, really she just hires the most skilled scientists.

“The best talent was the folks that we have and it ends up being we have three green card holders on our team. As far as ethnicities, we have on our team we have Indian, African-American, Korean, Chinese Pakistani, Moroccan and Hispanic people and that just kind of just makes up the people who helped us on a day-to-day basis,” she explains. Continue reading.

Mielad Ziaee, 2023-2024 All of Us Research Scholar

Mielad Ziaee, a 20-year-old student at the University of Houston, was tapped for a unique National Institutes of Health program. Photo via UH.edu

A Houston-area undergraduate student has been tapped for a prestigious national program that pairs early-career investigators with health research professionals.

Mielad Ziaee was selected for the National Institutes of Health’s 2023-2024 All of Us Research Scholar Program, which connects young innovators with experts "working to advance the field of precision medicine," according to a statement from UH. Ziaee – a 20-year-old majoring in psychology and minoring in biology, medicine and society who plans to graduate in 2025 — plans to research how genomics, or the studying of a person's DNA, can be used to impact health.

“I’ll be one of the ones that define what this field of personalized, precision medicine will look like in the future,” Ziaee said in a statement. “It’s exciting and it’s a big responsibility that will involve engaging diverse populations and stakeholders from different systems – from researchers to health care providers to policymakers.” Continue reading.

Health tech startup launches Houston study improve stroke patients recovery

now enrolling

A Houston-born company is enrolling patients in a study to test the efficacy of nerve stimulation to improve outcomes for stroke survivors.

Dr. Kirt Gill and Joe Upchurch founded NeuraStasis in 2021 as part of the TMC Biodesign fellowship program.

“The idea for the company manifested during that year because both Joe and I had experiences with stroke survivors in our own lives,” Gill tells InnovationMap. It began for Gill when his former college roommate had a stroke in his twenties.

“It’s a very unpredictable, sudden disease with ramifications not just for my best friend but for everyone in his life. I saw what it did to his family and caregivers and it's one of those things that doesn't have as many solutions for people to continue recovery and to prevent damage and that's an area that I wanted to focus myself on in my career,” Gill explains.

Gill and Upchurch arrived at the trigeminal and vagus nerves as a potential key to helping stroke patients. Gill says that there is a growing amount of academic literature that talks about the efficacy of stimulating those nerves. The co-founders met Dr. Sean Savitz, the director of the UTHealth Institute for Stroke and Cerebrovascular Diseases, during their fellowship. He is now their principal investigator for their clinical feasibility study, located at his facility.

The treatment is targeted for patients who have suffered an ischemic stroke, meaning that it’s caused by a blockage of blood flow to the brain.

“Rehabilitation after a stroke is intended to help the brain develop new networks to compensate for permanently damaged areas,” Gill says. “But the recovery process typically slows to essentially a standstill or plateau by three to six months after that stroke. The result is that the majority of stroke survivors, around 7.6 million in the US alone, live with a form of disability that prevents complete independence afterwards.”

NeuraStasis’ technology is intended to help patients who are past that window. They accomplish that with a non-invasive brain-stimulation device that targets the trigeminal and vagus nerves.

“Think of it kind of like a wearable headset that enables stimulation to be delivered, paired to survivors going through rehabilitation action. So the goal here is to help reinforce and rewire networks as they're performing specific tasks that they're looking to improve upon,” Gill explains.

The study, which hopes to enroll around 25 subjects, is intended to help people with residual arm and hand deficits six months or more after their ischemic stroke. The patients enrolled will receive nerve stimulation three times a week for six weeks. It’s in this window that Gill says he hopes to see meaningful improvement in patients’ upper extremity deficits.

Though NeuraStasis currently boasts just its two co-founders as full-time employees, the company is seeing healthy growth. It was selected for a $1.1 million award from the National Institutes of Health through its Blueprint MedTech program. The award was funded by the National Institute of Neurological Disorders and Stroke. The funding furthers NeuraStasis’ work for two years, and supports product development for work on acute stroke and for another product that will aid in emergency situations.

Gill says that he believes “Houston has been tailor-made for medical healthcare-focused innovation.”

NeuraStasis, he continues, has benefited greatly from its advisors and mentors from throughout the TMC, as well as the engineering talent from Rice, University of Houston and Texas A&M. And the entrepreneur says that he hopes that Houston will benefit as much from NeuraStasis’ technology as the company has from its hometown.

“I know that there are people within the community that could benefit from our device,” he says.